Cargando…
STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION
The titers of adenovirus and SV40 genetic carriers in hybrid preparations (E46(+)) can be quantitated by determining the percentage of cells showing neoantigens stainable with fluorescent antibody (FA) at 21 to 24 hours; both titers can be obtained with a single coverslip. The adenovirus and SV40 an...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1965
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138118/ https://www.ncbi.nlm.nih.gov/pubmed/4285252 |
_version_ | 1782143488608960512 |
---|---|
author | Rowe, Wallace P. Baum, Stephen G. Pugh, Wendell E. Hoggan, M. David |
author_facet | Rowe, Wallace P. Baum, Stephen G. Pugh, Wendell E. Hoggan, M. David |
author_sort | Rowe, Wallace P. |
collection | PubMed |
description | The titers of adenovirus and SV40 genetic carriers in hybrid preparations (E46(+)) can be quantitated by determining the percentage of cells showing neoantigens stainable with fluorescent antibody (FA) at 21 to 24 hours; both titers can be obtained with a single coverslip. The adenovirus and SV40 antigen-inducing titers so obtained are of the same order of magnitude in stock preparations of E46(+) grown in either African green monkey kidney (AGMK) or human embryonic kidney tissue culture (HEK), and are generally within one log of the infectivity titer. Quantitative studies of 50°C heat inactivation, ultracentrifugation, and equilibrium density gradient centrifugation of E46(+) gave no indication that SV40 neoantigen induction could be dissociated from adenovirus, whereas adenovirus and SV40 virus grown as a mixed infection were readily dissociated by these procedures. Pretreatment of HEK cells with a medium containing 5-fluorouracil desoxyriboside (FUDR) did not affect induction of either adenovirus or SV40 neoantigen or development of cytopathic effects after infection with E46(+), but did prevent formation of Ad. 7 viral antigen. |
format | Text |
id | pubmed-2138118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1965 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21381182008-04-17 STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION Rowe, Wallace P. Baum, Stephen G. Pugh, Wendell E. Hoggan, M. David J Exp Med Article The titers of adenovirus and SV40 genetic carriers in hybrid preparations (E46(+)) can be quantitated by determining the percentage of cells showing neoantigens stainable with fluorescent antibody (FA) at 21 to 24 hours; both titers can be obtained with a single coverslip. The adenovirus and SV40 antigen-inducing titers so obtained are of the same order of magnitude in stock preparations of E46(+) grown in either African green monkey kidney (AGMK) or human embryonic kidney tissue culture (HEK), and are generally within one log of the infectivity titer. Quantitative studies of 50°C heat inactivation, ultracentrifugation, and equilibrium density gradient centrifugation of E46(+) gave no indication that SV40 neoantigen induction could be dissociated from adenovirus, whereas adenovirus and SV40 virus grown as a mixed infection were readily dissociated by these procedures. Pretreatment of HEK cells with a medium containing 5-fluorouracil desoxyriboside (FUDR) did not affect induction of either adenovirus or SV40 neoantigen or development of cytopathic effects after infection with E46(+), but did prevent formation of Ad. 7 viral antigen. The Rockefeller University Press 1965-10-31 /pmc/articles/PMC2138118/ /pubmed/4285252 Text en Copyright © 1965 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Rowe, Wallace P. Baum, Stephen G. Pugh, Wendell E. Hoggan, M. David STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title | STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title_full | STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title_fullStr | STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title_full_unstemmed | STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title_short | STUDIES OF ADENOVIRUS SV40 HYBRID VIRUSES : I. ASSAY SYSTEM AND FURTHER EVIDENCE FOR HYBRIDIZATION |
title_sort | studies of adenovirus sv40 hybrid viruses : i. assay system and further evidence for hybridization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138118/ https://www.ncbi.nlm.nih.gov/pubmed/4285252 |
work_keys_str_mv | AT rowewallacep studiesofadenovirussv40hybridvirusesiassaysystemandfurtherevidenceforhybridization AT baumstepheng studiesofadenovirussv40hybridvirusesiassaysystemandfurtherevidenceforhybridization AT pughwendelle studiesofadenovirussv40hybridvirusesiassaysystemandfurtherevidenceforhybridization AT hogganmdavid studiesofadenovirussv40hybridvirusesiassaysystemandfurtherevidenceforhybridization |